PLOS digital health

Hypermobile Ehlers-Danlos Syndrome is more common than expected and linked to more other health problems and higher long COVID risk in a national group

Updated

Abstract

An estimated 1 in 800 individuals in the United States have Hypermobile Ehlers-Danlos Syndrome (hEDS).

  • Patients with hEDS were nearly three times more likely to develop Long COVID compared to matched controls despite similar rates of COVID-19 infection.
  • The increased risk of Long COVID was particularly significant among hEDS patients with overlapping conditions such as autonomic dysfunction, immune dysregulation, and chronic fatigue.
  • hEDS patients demonstrated higher odds of additional risk factors for severe or prolonged illness, including chronic lung issues, autoimmune conditions, depression, and cerebrovascular disease.
  • A subgroup of patients received their hEDS diagnosis only after being diagnosed with COVID-19 or Long COVID, showing a high prevalence of comorbid conditions like POTS and MCAS.
  • Findings indicate that hEDS is more prevalent than previously recognized and highlight the need for improved screening and integrated care for affected individuals.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free